Li Zhang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Induced Apoptosis

Top Venues

Science immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Enoch Tin, Jong Bok Lee, Ismat Khatri, Yoosu Na, Mark D Minden, Li Zhang
Double-negative T cells utilize a TNFα-JAK1-ICAM-1 cytotoxic axis against acute myeloid leukemia. Blood advances 8 (12) (2024)
Enoch Tin, Jong Bok Lee, Ismat Khatri, Yoosu Na, Mark D Minden, Li Zhang
Double-negative T cells utilize a TNFα-JAK1-ICAM-1 cytotoxic axis against acute myeloid leukemia. Blood advances 8 (12) (2024)
Enoch Tin, Jong Bok Lee, Ismat Khatri, Yoosu Na, Mark D Minden, Li Zhang
Double-negative T cells utilize a TNFα-JAK1-ICAM-1 cytotoxic axis against acute myeloid leukemia. Blood advances 8 (12) (2024)
Daniel Vasic, Jong Bok Lee, Yuki Leung, Ismat Khatri, Yoosu Na, Daniel Abate-Daga, Li Zhang
Allogeneic double-negative CAR-T cells inhibit tumor growth without off-tumor toxicities. Science immunology 7 (70) (2022)
Jong Bok Lee, Dilshad H Khan, Rose Hurren, Mingjing Xu, Yoosu Na, Hyeonjeong Kang, Sara Mirali, Xiaoming Wang, Marcela Gronda, Yulia Jitkova, Neil MacLean, Andrea Arruda, Zoe Alaniz, Marina Y Konopleva, Michael Andreeff, Mark D Minden, Li Zhang, Aaron David Schimmer
Venetoclax enhances T cell-mediated antileukemic activity by increasing ROS production. Blood 138 (3) (2021)